Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-35.73	68.21	106.13
Graham Fair Price	35.30	3506.13	2591.38
PEG	-76.70	0.28	-1.18
Price/Book	14.81	1.57	1.36
Price/Cash Flow	5306.89	4218.06	78.01
Prices/Earnings	-37.31	22.89	36.51
Price/Sales	15.90	4.77	4.11
Price/FCF	5306.89	4218.06	78.01
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	36.73	0.17	0.12
Operating Margin	199.11	0.05	0.02
ROA	84.34	0.01	< 0.005
ROE	< 0.005	0.02	83.14
ROIC	< 0.005	0.01	178.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	-0.07	41.93
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.59	2.00	239.08
EPS QOQ	-0.31	0.83	169.07
FCF QOQ	1.40	-0.98	-30.00
Revenue QOQ	0.08	< 0.005	-94.93
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	31.96	33.75	5.60
Days Sales Outstanding (DSO)	61.21	64.73	5.75
Inventory Turnover	2.82	2.67	-5.31
Debt/Capitalization	0.24	0.23	-4.28
Quick Ratio	2.58	2.46	-4.47
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5653.46	5652.19	-0.02
Cash	2296.47	1953.01	-14.96
Capex	-204.47	-58.11	71.58
Free Cash Flow	98.83	2.10	-97.88
Revenue	1873.80	1855.76	-0.96
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.10	3.00	-2.93
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.73	9.17	-41.71
Naive Interpretation	Member

06 - Financial Health · Bad

Rating